ES2061632T3 - Kluyveromyces como celula hospedante. - Google Patents

Kluyveromyces como celula hospedante.

Info

Publication number
ES2061632T3
ES2061632T3 ES88201632T ES88201632T ES2061632T3 ES 2061632 T3 ES2061632 T3 ES 2061632T3 ES 88201632 T ES88201632 T ES 88201632T ES 88201632 T ES88201632 T ES 88201632T ES 2061632 T3 ES2061632 T3 ES 2061632T3
Authority
ES
Spain
Prior art keywords
kluyveromyces
endogenous
product
hospitalizing
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88201632T
Other languages
English (en)
Other versions
ES2061632T5 (es
Inventor
Den Berg Johannes A Dr Van
Ooyen Albert J J Dr Van
Krijn Dr Rietveld
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gist Brocades NV
Original Assignee
Gist Brocades NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22144683&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2061632(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/078,539 external-priority patent/US4943529A/en
Application filed by Gist Brocades NV filed Critical Gist Brocades NV
Publication of ES2061632T3 publication Critical patent/ES2061632T3/es
Application granted granted Critical
Publication of ES2061632T5 publication Critical patent/ES2061632T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C12N9/2428—Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6478—Aspartic endopeptidases (3.4.23)
    • C12N9/6481—Pepsins (3.4.23.1; 3.4.23.2; 3.4.23.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01003—Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01108—Lactase (3.2.1.108)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA INVENCION PROPORCIONA HUESPEDES DE KLUYVEROMYCES Y CASETTES DE EXPRESION DE DNA PARA SU EMPLEO EN KLUYVEROMICES PARA LA TRANSCRIPCION DE DNA ENDOGENO Y/O EXOGENO Y PRODUCCION DE PEPTIDOS, PARA MEJORAR LA PRODUCCION DE UN PRODUCTO ENDOGENO O PARA PRODUCIR UN PRODUCTO EXOGENO. LOS HUESPEDES DE KLUYVEROMYCES SON PARTICULARMENTE UTILES PARA LA SECRECION DE UN PRODUCTO PEPTIDICO DESEADO, EN LAS QUE LAS SECUENCIAS SEÑAL PUEDEN SER NATIVAS DEL PEPTIDO O SER PROPORCIONADAS A PARTIR DE SECUENCIAS SEÑAL ENDOGENAS O EXOGENAS, QUE INCLUYEN SECUENCIAS SINTETICAS, FUNCIONALES EN LOS KLUYVEROMYCES. LE PROPORCIONA TAMBIEN UN PROCEDIMIENTO PARA TRANSFORMAR KLUYVEROMYCES DE FORMA EFICAZ.
ES88201632T 1987-07-28 1988-07-28 Kluyveromyces como celula hospedante. Expired - Lifetime ES2061632T5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/078,539 US4943529A (en) 1982-05-19 1987-07-28 Kluyveromyces as a host strain

Publications (2)

Publication Number Publication Date
ES2061632T3 true ES2061632T3 (es) 1994-12-16
ES2061632T5 ES2061632T5 (es) 2000-12-16

Family

ID=22144683

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88201632T Expired - Lifetime ES2061632T5 (es) 1987-07-28 1988-07-28 Kluyveromyces como celula hospedante.

Country Status (20)

Country Link
EP (1) EP0301670B2 (es)
JP (1) JPH02476A (es)
KR (1) KR970007024B1 (es)
CN (1) CN1026994C (es)
AR (1) AR247761A1 (es)
AT (1) ATE97446T1 (es)
AU (1) AU628018B2 (es)
CA (1) CA1323850C (es)
DE (1) DE3885668T3 (es)
DK (1) DK175203B1 (es)
ES (1) ES2061632T5 (es)
FI (1) FI107939B (es)
GR (1) GR3034358T3 (es)
HU (1) HU208553B (es)
IE (1) IE62458B1 (es)
IL (1) IL87258A (es)
NO (1) NO302485B1 (es)
NZ (1) NZ225597A (es)
PT (1) PT88133B (es)
ZA (1) ZA885536B (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5010182A (en) * 1987-07-28 1991-04-23 Chiron Corporation DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides
FR2649991B2 (fr) * 1988-08-05 1994-03-04 Rhone Poulenc Sante Utilisation de derives stables du plasmide pkd1 pour l'expression et la secretion de proteines heterologues dans les levures du genre kluyveromyces
CA2017176A1 (en) * 1989-05-22 1990-11-22 Yoshitomi Pharmaceutical Industries Ltd. Albumin gene-containing plasmid, transformant carrying same, production of such transformant and production of albumin
FR2650598B1 (fr) * 1989-08-03 1994-06-03 Rhone Poulenc Sante Derives de l'albumine a fonction therapeutique
US5326700A (en) * 1990-11-06 1994-07-05 Eli Lilly And Company DNA sequences encoding t-PA derivatives with cleavable sites
FR2677996B1 (fr) * 1991-06-21 1993-08-27 Rhone Poulenc Rorer Sa Vecteurs de clonage et/ou d'expression preparation et utilisation.
FR2678636A1 (fr) * 1991-07-02 1993-01-08 Rhone Poulenc Rorer Sa Procede de production de proteines recombinantes et cellules hote utilisees.
IT1251435B (it) * 1991-09-04 1995-05-09 Sclavo Spa Vettore genetico per la integrazione multipla stabile di sequenze di dna nel genoma dei lieviti kluyveromyces lactis e saccharomyces cerevisiae e plasmidi che lo contengono.
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
FR2692907B1 (fr) * 1992-06-25 1995-06-30 Rhone Poulenc Rorer Sa Levures kluyveromyces modifiees, preparation et utilisation.
FR2693475B1 (fr) * 1992-07-08 1994-09-02 Rhone Poulenc Rorer Sa Procédé d'identification et/ou de clonage de promoteurs transcriptionnels, et utilisation de ces promoteurs pour l'expression de gènes.
GB9526733D0 (en) 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
GB9907461D0 (en) 1999-03-31 1999-05-26 King S College London Neurite regeneration
US6265186B1 (en) 1997-04-11 2001-07-24 Dsm N.V. Yeast cells comprising at least two copies of a desired gene integrated into the chromosomal genome at more than one non-ribosomal RNA encoding domain, particularly with Kluyveromyces
CN1059236C (zh) * 1997-04-24 2000-12-06 复旦大学 脆壁克鲁维酵母的高效转化系统
US8372620B2 (en) 1998-12-23 2013-02-12 Dupont Nutrition Biosciences Aps Bacterial xylanases
EP2206720A1 (en) 2000-04-12 2010-07-14 Human Genome Sciences, Inc. Albumin fusion proteins
US6946134B1 (en) 2000-04-12 2005-09-20 Human Genome Sciences, Inc. Albumin fusion proteins
GB0020498D0 (en) 2000-08-18 2000-10-11 Sterix Ltd Compound
ES2394481T3 (es) 2000-09-21 2013-02-01 Basf Se Xilanasa de talaromyces
CA2706364A1 (en) 2000-12-07 2002-06-13 Dsm Ip Assets B.V. Method for the prevention or reduction of haze in beverages
ATE475324T1 (de) 2000-12-07 2010-08-15 Dsm Ip Assets Bv Mit carboxy-terminal prolin peptide angereicherte proteinhydrolysate
US7507413B2 (en) 2001-04-12 2009-03-24 Human Genome Sciences, Inc. Albumin fusion proteins
GB0116453D0 (en) 2001-07-05 2001-08-29 Imp College Innovations Ltd Method
EP2042196B1 (en) 2001-10-10 2016-07-13 ratiopharm GmbH Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF)
EP2261250B1 (en) 2001-12-21 2015-07-01 Human Genome Sciences, Inc. GCSF-Albumin fusion proteins
AU2003228145B2 (en) 2002-06-07 2009-10-08 Dsm Ip Assets B.V. Improved method for the prevention or reduction of haze in beverages
TWI328612B (en) 2002-07-25 2010-08-11 Dsm Ip Assets Bv Genes and their encoded polypeptides involved in the biosynthetic pathway of vitamin b12, vectors and host cells comprising the genes, and process for producing vitamin b12
CA2513213C (en) 2003-01-22 2013-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
EP2055189A1 (en) 2003-04-09 2009-05-06 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
GB0403864D0 (en) 2004-02-20 2004-03-24 Ucl Ventures Modulator
ES2246175B1 (es) * 2004-07-30 2007-03-16 Felix Claverie Martin "procedimiento para producir quimosina caprina recombinante para la coagulacion de la leche de cabra en la fabricacion de queso".
ES2454167T3 (es) 2005-11-28 2014-04-09 Dsm Ip Assets B.V. Preparación de enzima que produce un sabor puro
GB0600406D0 (en) 2006-01-10 2006-02-15 Univ Bath Crystal
EP1816201A1 (en) 2006-02-06 2007-08-08 CSL Behring GmbH Modified coagulation factor VIIa with extended half-life
PL2333056T3 (pl) 2006-04-13 2014-09-30 Dsm Ip Assets Bv Ciekła kompozycja zawierająca proteazę asparaginową
BRPI0807768A2 (pt) 2007-02-20 2014-06-24 Dsm Ip Assests Bv Nova sialidase.
JP2010521188A (ja) 2007-03-22 2010-06-24 ディーエスエム アイピー アセッツ ビー．ブイ． 新規リシルオキシダーゼ
CN101983240B (zh) 2008-03-18 2012-11-14 国立大学法人山口大学 凝集性酵母及其制备方法
WO2011101339A2 (en) 2010-02-18 2011-08-25 Dsm Ip Assets B.V. Fermentation broth and filtration filter cake and uses thereof
WO2012007446A1 (en) 2010-07-13 2012-01-19 Dsm Ip Assets B.V. Use of a mutarotase in the production of dried powders
WO2012007445A1 (en) 2010-07-13 2012-01-19 Dsm Ip Assets B.V. Mutarotase in crystallization
CN115806889B (zh) * 2022-09-28 2024-06-11 山东大学 一种提高基因表达水平的酿酒酵母工程菌及其构建方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL66614A (en) * 1981-08-28 1985-09-29 Genentech Inc Method of constructing a dna sequence encoding a polypeptide,microbial production of human serum albumin,and pharmaceutical compositions comprising it
GT198302091A (es) * 1982-05-05 1984-10-25 Activador de plasminogeno de tejido humano a),b),c).
JP2608540B2 (ja) * 1982-05-19 1997-05-07 ギスト ブロカデス ナ−ムロ−ゼ フエンノ−トチヤツプ クルイベロミセス種のためのクローニング系
DE3382547D1 (de) * 1983-01-12 1992-05-27 Chiron Corp Sekretorische expression in eukaryoten.
IT1203758B (it) * 1986-03-27 1989-02-23 Univ Roma Vettori di clonazione e di espressione di geni eterologhi in lieviti e lieviti trasformati con tali vettori

Also Published As

Publication number Publication date
FI883540A0 (fi) 1988-07-28
IE882314L (en) 1989-01-28
DE3885668T2 (de) 1994-05-05
HUT47637A (en) 1989-03-28
IE62458B1 (en) 1995-02-08
IL87258A0 (en) 1988-12-30
DK422188D0 (da) 1988-07-28
ATE97446T1 (de) 1993-12-15
NO883347D0 (no) 1988-07-28
EP0301670A1 (en) 1989-02-01
AU628018B2 (en) 1992-09-10
NO302485B1 (no) 1998-03-09
HU208553B (en) 1993-11-29
KR890002407A (ko) 1989-04-10
DK422188A (da) 1989-01-29
ES2061632T5 (es) 2000-12-16
EP0301670B1 (en) 1993-11-18
PT88133B (pt) 1995-03-01
DK175203B1 (da) 2004-07-05
DE3885668T3 (de) 2000-08-17
AR247761A1 (es) 1995-03-31
JPH02476A (ja) 1990-01-05
CN1026994C (zh) 1994-12-14
ZA885536B (en) 1989-04-26
PT88133A (pt) 1989-06-30
FI107939B (fi) 2001-10-31
NZ225597A (en) 1991-08-27
AU2014888A (en) 1989-03-02
FI883540L (fi) 1989-01-29
CN1040052A (zh) 1990-02-28
CA1323850C (en) 1993-11-02
EP0301670B2 (en) 2000-06-14
NO883347L (no) 1989-01-30
IL87258A (en) 1994-02-27
KR970007024B1 (ko) 1997-05-02
DE3885668D1 (de) 1993-12-23
GR3034358T3 (en) 2000-12-29

Similar Documents

Publication Publication Date Title
ES2061632T3 (es) Kluyveromyces como celula hospedante.
ES2150916T3 (es) Utilizacion del acido gentisico o del alcohol gentisilico para estabilizar peptidos y proteinas radiomarcados.
DK0471754T3 (da) Produktion af vaskulær endotelcelle vækstfaktor, samt DNA kodende for denne
ES2169095T3 (es) Proteinas con actividad de factor viii, procedimiento para su produccion utilizando celulas modificadas por ingenieria genetica y composiciones farmaceuticas que los contienen.
ES2127164T1 (es) Expresion de lactoferrina recombinante y fragmentos polipeptidicos de lactoferrina procesados a partir de un producto de fusion en aspergillus.
ES8602121A1 (es) Procedimiento para producir un vehiculo de expresion para la formacion de uroquinasa humana
ES2104565T3 (es) Determinantes anti-receptor de celulas t como tratamiento de enfermedades autoinmunes.
ES2094159T3 (es) Produccion de factor de crecimiento de celulas endoteliales vasculares.
ES2072900T3 (es) Expresion elevada de proteinas en levadura.
FI101720B1 (fi) Synteettisen DNA:n konstruointi ja sen käyttö suurten polypeptidien synteesissä
ES2054040T3 (es) Nueva forma galenica del fenofibrato.
DE60025015D1 (de) Verfahren zur herstellung von rekombinanten proteinen mittels inhibitoren von apoptose
ES8801851A1 (es) Un metodo para producir bacterianamente un polipeptido heteralogo que tiene actividad somatotropinica.
ES8608885A1 (es) Procedimiento para distinguir celulas normales de malignas, en una mezcla de las mismas
MX9400224A (es) Poliuretanos encamisados en piel de plastico, que tienen apariencia superficial mejorada.
CH491864A (de) Verfahren zur Herstellung biologisch aktiver Peptide
ES2068201T3 (es) Produccion de kalicreina.
ES2193192T3 (es) Receptores de interleuquina-15.
AT322488B (de) Verfahren zur herstellung von wasserunlöslichen proteinpräparaten, insbesondere von wasserunlöslichen penicillinacylasepräparaten
MX9606369A (es) Supresion del crecimiento de celulas tumorales mediante el ectodominio de syndecan-1.
DE3261304D1 (en) Retro-inverso analogues of c-terminal penta and hexapeptides of substance p.
AT322863B (de) Hartschaumstoff zur herstellung von tragenden, gegen hochspannung isolierenden teilen von elektrischen einrichtungen und apparaten
HUT65369A (en) Bcrf1 proteins as inhibitors of gamma-interferon
JPS56127315A (en) Method for obtaining human relaxin
MX9307007A (es) Vectores de expresion para tripsina y tripsinogeno de bovino y celulashuesped transformadoras con los mismos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 301670

Country of ref document: ES